Dagrocorat

From Food & Medicine Encyclopedia

Dagrocorat is a nonsteroidal but steroid-like selective glucocorticoid receptor modulator (SGRM) which was under development for the treatment of rheumatoid arthritis but was never marketed.

Dagrocorat
Dagrocorat

Developmental code name[edit]

The delopmental code names were: PF-00251802, PF-251802

Never marketed[edit]

The medication was never marketed by the pharmaceutical company for unknown reasons.

Mechanism of action[edit]

Dagrocorat is a novel and dissociated glucocorticoid receptor agonist.

Originator[edit]

Pfizer

Class of drug[edit]

Anti-inflammatories; Antirheumatics; Phenanthrenes; Pyridines; Small molecules

Orphan Drug Status[edit]

No

New Molecular Entity[edit]

Yes

Highest Development Phases[edit]

Phase 1

Current status[edit]

Discontinued

Proposed indication[edit]

Rheumatoid arthritis

Most Recent Events[edit]

  • 27 Jan 2010Discontinued - Phase-I for Rheumatoid arthritis in USA (unspecified route)
  • 03 Oct 2008Phase-I trials in Rheumatoid arthritis in USA (unspecified route)

Related molecules[edit]

Dagrocorat-2


Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.